Literature DB >> 24764145

More than skin-deep: the many dimensions of the psoriatic disease.

Wolf-Henning Boehncke1, Sandra Boehncke2.   

Abstract

Psoriasis is among the most common skin diseases, exhibiting a wide spectrum of clinical manifestations. Joint involvement in the form of psoriatic arthritis is readily recognised, but both frequency and severity of this manifestation have long been underestimated. More recently, additional important diseases have been found to be associated with psoriasis, including the metabolic syndrome (or components thereof), cardiovascular diseases, lymphoma, and anxiety/depression. In the past, psoriasis treatment aimed at suppressing acute rashes. Current concepts regard psoriasis as a chronic systemic inflammatory condition and cardiovascular risk factor. In the light of this concept, long-term disease control through systemic maintenance therapy is increasingly recommended by experts. This approach became feasible with the approval of numerous biologics for the treatment of psoriasis. But to really address all medical needs of psoriasis patients, a truly interdisciplinary, comprehensive management approach is needed. Several national societies have already published algorithms to ensure that this need will be implemented in the daily practice of dermatologists and nondermatologists alike.

Entities:  

Mesh:

Year:  2014        PMID: 24764145     DOI: 10.4414/smw.2014.13968

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  11 in total

Review 1.  Non-alcoholic fatty liver disease and psoriasis: So far, so near.

Authors:  Giulia Ganzetti; Anna Campanati; Annamaria Offidani
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background.

Authors:  Giulia Ganzetti; Anna Campanati; Elisa Molinelli; Annamaria Offidani
Journal:  World J Cardiol       Date:  2016-02-26

3.  Psoriasis and Diabetes: A Multicenter Study in 222078 Type 2 Diabetes Patients Reveals High Levels of Depression.

Authors:  Anke Schwandt; Dominik Bergis; Albrecht Dapp; Stefan Ebner; Peter M Jehle; Stefan Köppen; Alexander Risse; Stefan Zimny; Reinhard W Holl
Journal:  J Diabetes Res       Date:  2015-08-17       Impact factor: 4.011

4.  Psoriasis drug development and GWAS interpretation through in silico analysis of transcription factor binding sites.

Authors:  William R Swindell; Mrinal K Sarkar; Philip E Stuart; John J Voorhees; James T Elder; Andrew Johnston; Johann E Gudjonsson
Journal:  Clin Transl Med       Date:  2015-03-19

5.  Increased frequency of activated CD8+ T cell effectors in patients with psoriatic arthritis.

Authors:  Marco Diani; Fabio Casciano; Laura Marongiu; Matteo Longhi; Andrea Altomare; Paolo D Pigatto; Paola Secchiero; Roberto Gambari; Giuseppe Banfi; Angelo A Manfredi; Gianfranco Altomare; Francesca Granucci; Eva Reali
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

Review 6.  Management of psoriasis as a systemic disease: what is the evidence?

Authors:  N J Korman
Journal:  Br J Dermatol       Date:  2019-10-15       Impact factor: 9.302

7.  Characterizing Outcomes and Unmet Needs Among Patients in the United States with Mild-to-Moderate Plaque Psoriasis Using Prescription Topicals.

Authors:  Shaloo Gupta; Steven Garbarini; Tara Nazareth; Ibrahim Khilfeh; Halley Costantino; David Kaplan
Journal:  Dermatol Ther (Heidelb)       Date:  2021-10-14

8.  Metabolic syndrome affects narrow-band UVB phototherapy response in patients with psoriasis.

Authors:  Wang Rui; Ding Xiangyu; Xie Fang; Gong Long; Yang Yi; Wang Wenjuan; Hao Tian; Zhang Xiaoning; Zhou Yong; Fan Jianfeng; Li Hengjin; Li Chengxin
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 9.  Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients.

Authors:  Ellie C Stefanadi; Georgios Dimitrakakis; Christos-Konstantinos Antoniou; Dimitrios Challoumas; Nikita Punjabi; Inetzi Aggeliki Dimitrakaki; Sangeeta Punjabi; Christodoulos I Stefanadis
Journal:  Diabetol Metab Syndr       Date:  2018-02-21       Impact factor: 3.320

Review 10.  Cutaneous and Mucosal Manifestations Associated with Celiac Disease.

Authors:  Luis Rodrigo; Valia Beteta-Gorriti; Nuria Alvarez; Celia Gómez de Castro; Alvaro de Dios; Laura Palacios; Jorge Santos-Juanes
Journal:  Nutrients       Date:  2018-06-21       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.